Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
Condition(s):Biliary Tract NeoplasmsLast Updated:October 27, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Biliary Tract NeoplasmsLast Updated:October 27, 2014Completed
Condition(s):Biliary Tract NeoplasmsLast Updated:February 17, 2012Completed
Condition(s):Biliary Tract NeoplasmsLast Updated:November 30, 2023Terminated
Condition(s):Biliary Tract NeoplasmsLast Updated:January 23, 2014Completed
Condition(s):Biliary Tract NeoplasmsLast Updated:February 9, 2018Unknown status
Condition(s):Biliary Tract NeoplasmsLast Updated:February 12, 2015Unknown status
Condition(s):Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Gastrointestinal Cancer; Recurrent Extrahepatic Bile Duct Cancer; Recurrent Gallbladder Cancer; Unresectable Extrahepatic Bile Duct Cancer; Unresectable Gallbladder CancerLast Updated:May 28, 2014Completed
Condition(s):Biliary Tract Cancer; Biliary Tract NeoplasmsLast Updated:February 13, 2024Completed
Condition(s):Hepatocellular Carcinoma; Biliary Tract NeoplasmsLast Updated:December 19, 2023Recruiting
Condition(s):Pancreatic Cancer; Biliary Tract NeoplasmsLast Updated:April 17, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.